{"version":"1.0","provider_name":"Qeen Biotechnologies","provider_url":"https:\/\/qeen-bio.com\/fr\/","author_name":"qeenbiotechnologies","author_url":"https:\/\/qeen-bio.com\/fr\/author\/qeenbiotherapeutics\/","title":"Mr. Mark Engel - Qeen Biotechnologies","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"34p9WG3qCi\"><a href=\"https:\/\/qeen-bio.com\/fr\/team\/mr-mark-engel\/\">Mr. Mark Engel<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/qeen-bio.com\/fr\/team\/mr-mark-engel\/embed\/#?secret=34p9WG3qCi\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Mr. Mark Engel\u00a0\u00bb &#8212; Qeen Biotechnologies\" data-secret=\"34p9WG3qCi\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/qeen-bio.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/qeen-bio.com\/wp-content\/uploads\/2018\/07\/Untitled-design-12.jpg","thumbnail_width":561,"thumbnail_height":608,"description":"M. Mark Engel, Pr\u00e9sident, est un entrepreneur chevronn\u00e9 dans le domaine des sciences de la vie, avec un parcours marqu\u00e9 par la cr\u00e9ation et la vente d'entreprises prosp\u00e8res dans le secteur de la sant\u00e9. Il pr\u00e9side actuellement deux entreprises de biotechnologie de pr\u00e9cision : l'une se concentrant sur les solutions antibact\u00e9riennes en agriculture et l'autre sur les infections en sant\u00e9 humaine. En tant que directeur g\u00e9n\u00e9ral de son fonds familial, M. Engel supervise les investissements dans les industries de la sant\u00e9 et de l'agriculture. Il est titulaire d'un dipl\u00f4me en droit de la Notre Dame Law School et apporte une vaste exp\u00e9rience \u00e0 ses fonctions de direction."}